Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Breath-activated inhaler from IVAX licensed to Glaxo Wellcome

Dec. 31, 1996

Endorex licenses oral delivery technology

Dec. 24, 1996

Novel adenylate cyclase offered for licensing

Dec. 20, 1996

MRC offers licenses for work relating to pathological vasoconstriction

Dec. 20, 1996

Genelabs-DuPont Merck joint effort to discover gene-regulating drugs

Dec. 20, 1996

FDA medical devices advisory committee to meet today

Dec. 20, 1996

Knoll licenses technology for use in cardiovascular research

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Inactivation of SIV by LifeTECH's blood sterilization technology

Dec. 17, 1996

Celox Laboratories' ViaStem receives patent coverage

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...